• Actionable Healthcare Insights Through

     
     

    Physician-Patient Conversations

  • Complementary Methodologies Provide Revealing Context

    Only Verilogue augments dialogue research with multi-modal qualitative research methodologies that work together with our dialogue findings to uncover meaningful connections, identify unique insights, and increase efficiencies.

  • Explore Customer Motivators Across the Patient Journey

    Verilogue offers comprehensive expertise in determining how exam-room dialogue can drive your marketing strategy to be more relevant at every stage of commercialization.

  • Bring Your Sales Reps Inside the Exam Room

    By leveraging the only training solution that uses real, unscripted doctor-patient dialogue, Verilogue's Customer-Acumen training improves sales representative appreciation for customer conversations and challenges, and enhances their ability to conduct meaningful discussions with target clinicians.

  • Maximize Efficiency in Working with Research Data

    Built specifically for market researchers, RevealMR is a cloud-based solution that revolutionizes the way you store, share, and mine volumes of unstructured and structured research data.

  • Dialogue in International Markets

    Verilogue Global Voice offers exam-room dialogue programs for countries across the Americas, Europe, and Asia-Pacific. Our native linguists and cultural experts help you translate these doctor and patient conversations into actionable insights and marketing programs.

News from

Verilogue

Verilogue provides a deeper understanding of the patient experience

In the March 2014 issue of Quirk's, Jim Hickey outlines a research process by which pharmaceutical brands can learn what life is really like for patients.

Powerful

Resources

Infographic

Global Voice Comparison

Verilogue Summit

Emotional Brand Loyalty and Other Successes from the Hospitality Industry

More Resources »

eBook

The Market Researcher’s Guide to Knowledge Management

Trusted by the World's Most Recognized Pharmaceutical Organizations

  •  
     
     
     
     
  •  
     
     
     
     
  •  
     
     
     
     
  •  
     
     
     
     
  •  
     
     
     
     
  •  
     
     
     
     
  •  
     
     
     
     
  •  
     
     
     
     
  •